These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 32159116)

  • 41. Direct oral anticoagulants: key considerations for use to prevent stroke in patients with nonvalvular atrial fibrillation.
    Ment J
    Vasc Health Risk Manag; 2015; 11():317-32. PubMed ID: 26089678
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry: protocol for a prospective, observational nationwide cohort study.
    Guo Y; Wang Y; Li X; Shan Z; Shi X; Xi G; Lip GYH;
    BMJ Open; 2018 May; 8(5):e020191. PubMed ID: 29730624
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Left atrial appendage closure for prevention of death, stroke, and bleeding in patients with nonvalvular atrial fibrillation.
    Gloekler S; Saw J; Koskinas KC; Kleinecke C; Jung W; Nietlispach F; Meier B
    Int J Cardiol; 2017 Dec; 249():234-246. PubMed ID: 28882323
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [New treatments for stroke and thromboembolism prevention in atrial fibrillation].
    Shiyovich A; Khalameizer V; Katz A
    Harefuah; 2014 Jan; 153(1):32-8, 64. PubMed ID: 24605405
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
    Cheng JW; Barillari G
    J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Atrial fibrillation and heart failure: Factors influencing the choice of oral anticoagulant.
    Brown LAE; Boos CJ
    Int J Cardiol; 2017 Jan; 227():863-868. PubMed ID: 28029411
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control.
    Skanes AC; Healey JS; Cairns JA; Dorian P; Gillis AM; McMurtry MS; Mitchell LB; Verma A; Nattel S;
    Can J Cardiol; 2012; 28(2):125-36. PubMed ID: 22433576
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical outcomes in elderly atrial fibrillation patients at increased bleeding risk treated with very low dose vs. regular-dose non-vitamin K antagonist oral anticoagulants: a nationwide cohort study.
    Chan YH; Chao TF; Chen SW; Lee HF; Li PR; Yeh YH; Kuo CT; See LC; Lip GYH
    Eur Heart J Cardiovasc Pharmacother; 2023 Dec; 9(8):681-691. PubMed ID: 37580139
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictors and Outcomes of Oral Anticoagulant Deprescribing in Geriatric Inpatients With Atrial Fibrillation: A Retrospective Multicenter Cohort Study.
    Brunetti E; Presta R; Okoye C; Filippini C; Raspo S; Bruno G; Marabotto M; Monzani F; Bo M
    J Am Med Dir Assoc; 2024 Mar; 25(3):545-551.e4. PubMed ID: 38359897
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Practical Considerations for the Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation.
    Stacy Z; Richter S
    Clin Appl Thromb Hemost; 2017 Jan; 23(1):5-19. PubMed ID: 26988835
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Net clinical benefit of non-vitamin K antagonist oral anticoagulants in atrial fibrillation and chronic kidney disease: a trade-off analysis from four phase III clinical trials.
    Gu ZC; Kong LC; Yang SF; Wei AH; Wang N; Ding Z; Zhang C; Liu XY; Zheng YL; Lin HW
    Cardiovasc Diagn Ther; 2019 Oct; 9(5):410-419. PubMed ID: 31737513
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stroke and thromboembolism prevention in atrial fibrillation.
    Jame S; Barnes G
    Heart; 2020 Jan; 106(1):10-17. PubMed ID: 31533990
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Non-Vitamin K Antagonist Oral Anticoagulants for Cardioversion in Atrial Fibrillation: An Updated Meta-analysis.
    Renda G; Ricci F; De Caterina R
    Am J Med; 2017 Apr; 130(4):457-461. PubMed ID: 27751896
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of Atrial Fibrillation and Antithrombotic Therapy in Hemodialysis Patients: Cross-Sectional Results of the Vienna InVestigation of AtriaL Fibrillation and Thromboembolism in Patients on HemoDIalysis (VIVALDI).
    Königsbrügge O; Posch F; Antlanger M; Kovarik J; Klauser-Braun R; Kletzmayr J; Schmaldienst S; Auinger M; Zuntner G; Lorenz M; Grilz E; Stampfel G; Steiner S; Pabinger I; Säemann M; Ay C
    PLoS One; 2017; 12(1):e0169400. PubMed ID: 28052124
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices.
    Savelieva I; Bajpai A; Camm AJ
    Ann Med; 2007; 39(5):371-91. PubMed ID: 17701479
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Antithrombotic therapy in atrial fibrillation: state of the art and perspectives].
    Ricci F; Renda G; De Caterina R
    G Ital Cardiol (Rome); 2013 Jan; 14(1):21-34. PubMed ID: 23258202
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacological Therapy in Stroke Prophylaxis - The New versus the Old Agents.
    Maan A; Heist EK; Ruskin JN; Mansour M
    J Atr Fibrillation; 2013; 6(1):825. PubMed ID: 28496855
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease.
    Kimachi M; Furukawa TA; Kimachi K; Goto Y; Fukuma S; Fukuhara S
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011373. PubMed ID: 29105079
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term oral anticoagulation for atrial fibrillation in low and middle income countries.
    Ramakumar V; Benz AP; Karthikeyan G
    Indian Heart J; 2021; 73(2):244-248. PubMed ID: 33865530
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antithrombotic therapy for stroke prevention in patients with atrial fibrillation in Japan.
    Maruhashi T; Higashi Y
    Expert Opin Pharmacother; 2020 Dec; 21(17):2115-2124. PubMed ID: 32749891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.